Related Experiment Videos
Yb-DTPA, a novel contrast agent in magnetic resonance imaging: application to rat kidney
S K Sarkar1, R E Rycyna, R E Lenkinski
1Department of Physical & Structural Chemistry, Smith Kline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406.
Magnetic Resonance in Medicine
|February 1, 1991
Abstract:
We have developed a novel contrast agent, ytterbium-diethylenetriamine pentaacetic acid (Yb-DTPA), for magnetic resonance imaging (MRI) and its mechanism of action is predominantly by the susceptibility mechanism. We have applied this contrast agent for renal MRI studies. We also demonstrate that Yb-DTPA has a renal clearance similar to that of inulin in rats and may therefore be useful for the estimation of glomerular filtration rate.